Recently, a radiomics-based biomarker (Rad score) was shown to predict the presence of tumor-infiltrating CD8 +TILs in hepatocellular carcinoma and to identify potential candidates for immunotherapy [50]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.